Symbols / WGS Stock $68.53 +3.46% GeneDx Holdings Corp.

Healthcare • Diagnostics & Research • United States • NMS
WGS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Diagnostics & Research
CEO Ms. Katherine A. Stueland
Exch · Country NMS · United States
Market Cap 2.01B
Enterprise Value 1.95B
Income -21.02M
Sales 427.54M
FCF (ttm) 38.06M
Book/sh 10.54
Cash/sh 5.85
Employees 1,300
Insider 10d
IPO Nov 04, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E 33.31
PEG
P/S 4.69
P/B 6.50
P/C
EV/EBITDA 154.05
EV/Sales 4.56
Quick Ratio 2.26
Current Ratio 2.46
Debt/Eq 36.72
LT Debt/Eq
EPS (ttm) -0.73
EPS next Y 2.06
EPS Growth
Revenue Growth 26.50%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2026-05-04
Earnings (prior) 2026-02-23
ROA -1.55%
ROE -7.60%
ROIC
Gross Margin 69.74%
Oper. Margin -10.60%
Profit Margin -4.92%
Shs Outstand 29.29M
Shs Float 20.85M
Insider Own 12.56%
Instit Own 104.97%
Short Float 26.61%
Short Ratio 5.60
Short Interest 3.96M
52W High 170.87
vs 52W High -59.89%
52W Low 55.17
vs 52W Low 24.22%
Beta 2.19
Impl. Vol. 0.78%
Rel Volume 0.62
Avg Volume 742.16K
Volume 457.19K
Target (mean) $136.11
Tgt Median $150.00
Tgt Low $90.00
Tgt High $177.00
# Analysts 9
Recom Strong_buy
Prev Close $66.24
Price $68.53
Change 3.46%
About

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$68.53
Low
$90.00
High
$177.00
Mean
$136.11

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-20 main Canaccord Genuity Buy → Buy $100
2026-03-30 main Guggenheim Buy → Buy $100
2026-02-24 main Piper Sandler Overweight → Overweight $130
2026-02-24 main BTIG Buy → Buy $170
2026-02-09 up Wells Fargo Equal-Weight → Overweight $155
2025-12-22 main Canaccord Genuity Buy → Buy $170
2025-12-15 main Wells Fargo Equal-Weight → Equal-Weight $155
2025-12-12 main BTIG Buy → Buy $200
2025-11-04 main Wells Fargo Equal-Weight → Equal-Weight $140
2025-10-29 main Canaccord Genuity Buy → Buy $160
2025-10-29 main Guggenheim Buy → Buy $170
2025-10-29 main BTIG Buy → Buy $165
2025-10-22 main BTIG Buy → Buy $140
2025-10-20 init Canaccord Genuity — → Buy $155
2025-09-11 main Piper Sandler Overweight → Overweight $140
2025-08-04 main Piper Sandler Overweight → Overweight $120
2025-07-30 main Wells Fargo Equal-Weight → Equal-Weight $95
2025-07-09 init Piper Sandler — → Overweight $110
2025-06-30 main Guggenheim Buy → Buy $115
2025-05-09 up Jefferies Hold → Buy $80
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-26 STUELAND KATHERINE Chief Executive Officer 46,933 $61.29 $2,964,841
2026-03-26 STUELAND KATHERINE Chief Executive Officer 80,000
2026-03-26 FEELEY KEVIN Chief Financial Officer 8,818 $61.29 $557,051
2026-03-26 FEELEY KEVIN Chief Financial Officer 16,250
2026-03-16 STUELAND KATHERINE Chief Executive Officer 17,179 $76.35 $1,319,291
2026-03-16 STUELAND KATHERINE Chief Executive Officer 30,671
2026-03-16 FEELEY KEVIN Chief Financial Officer 5,706 $76.35 $438,203
2026-03-16 FEELEY KEVIN Chief Financial Officer 11,012
2026-03-09 STUELAND KATHERINE Chief Executive Officer 3,678 $86.75 $319,059
2026-03-09 STUELAND KATHERINE Chief Executive Officer 6,546
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
427.54
+39.97%
305.45
+50.79%
202.57
-13.69%
234.69
Operating Revenue
416.67
+37.90%
302.16
+54.43%
195.65
-13.94%
227.33
Cost Of Revenue
129.37
+16.49%
111.05
-1.34%
112.56
-56.95%
261.44
Reconciled Cost Of Revenue
129.37
+16.49%
111.05
-1.34%
112.56
-56.95%
261.44
Gross Profit
298.17
+53.38%
194.40
+115.98%
90.01
+436.47%
-26.75
Operating Expense
311.25
+43.03%
217.61
-16.37%
260.20
-39.59%
430.76
Research And Development
72.03
+57.53%
45.72
-21.53%
58.27
-32.41%
86.20
Selling General And Administration
239.22
+39.17%
171.89
-14.05%
199.98
-40.88%
338.24
Selling And Marketing Expense
88.41
+31.22%
67.37
+10.52%
60.96
-50.07%
122.08
General And Administrative Expense
150.82
+44.30%
104.52
-24.82%
139.02
-35.69%
216.17
Other Gand A
150.82
+44.30%
104.52
-24.82%
139.02
-35.69%
216.17
Other Operating Expenses
3.41
+74.09%
1.96
-69.00%
6.31
Total Expenses
440.62
+34.06%
328.66
-11.83%
372.76
-46.15%
692.20
Operating Income
-13.08
+43.67%
-23.21
+86.36%
-170.19
+62.80%
-457.51
Total Operating Income As Reported
-13.08
+43.67%
-23.21
+87.15%
-180.60
+72.95%
-667.65
EBITDA
12.15
+1064.05%
-1.26
+99.08%
-136.46
+65.73%
-398.20
Normalized EBITDA
13.35
+10.25%
12.11
+109.52%
-127.23
+50.74%
-258.28
Reconciled Depreciation
25.22
+14.90%
21.95
-34.92%
33.73
-43.12%
59.31
EBIT
-13.08
+43.67%
-23.21
+86.36%
-170.19
+62.80%
-457.51
Total Unusual Items
-1.20
+90.99%
-13.37
-44.82%
-9.23
+93.40%
-139.92
Total Unusual Items Excluding Goodwill
-1.20
+90.99%
-13.37
-44.82%
-9.23
+93.40%
-139.92
Special Income Charges
0.00
0.00
+100.00%
-10.40
+95.05%
-210.15
Write Off
0.00
0.00
-100.00%
10.40
-95.05%
210.15
Net Income
-21.02
+59.80%
-52.29
+70.25%
-175.77
+67.98%
-548.98
Pretax Income
-21.14
+59.84%
-52.63
+70.21%
-176.69
+70.45%
-598.03
Net Non Operating Interest Income Expense
-2.54
+16.26%
-3.03
-372.17%
1.11
+267.27%
-0.67
Interest Expense Non Operating
3.21
Net Interest Income
-2.54
+16.26%
-3.03
-372.17%
1.11
+267.27%
-0.67
Interest Expense
3.21
Interest Income Non Operating
2.54
Interest Income
2.54
Other Income Expense
-5.52
+79.07%
-26.38
-246.57%
-7.61
+94.56%
-139.86
Other Non Operating Income Expenses
-4.32
+66.83%
-13.01
-903.83%
1.62
+2740.35%
0.06
Gain On Sale Of Security
-1.20
+90.99%
-13.37
-1242.74%
1.17
-98.33%
70.23
Tax Provision
-0.12
+66.18%
-0.34
+62.96%
-0.93
+98.11%
-49.05
Tax Rate For Calcs
0.00
-23.28%
0.00
+24.35%
0.00
-93.61%
0.00
Tax Effect Of Unusual Items
-0.01
+93.09%
-0.09
-80.10%
-0.05
+99.58%
-11.47
Net Income Including Noncontrolling Interests
-21.02
+59.80%
-52.29
+70.25%
-175.77
+67.98%
-548.98
Net Income From Continuing Operation Net Minority Interest
-21.02
+59.80%
-52.29
+70.25%
-175.77
+67.98%
-548.98
Net Income From Continuing And Discontinued Operation
-21.02
+59.80%
-52.29
+70.25%
-175.77
+67.98%
-548.98
Net Income Continuous Operations
-21.02
+59.80%
-52.29
+70.25%
-175.77
+67.98%
-548.98
Normalized Income
-19.82
+49.18%
-39.00
+76.59%
-166.58
+60.39%
-420.54
Net Income Common Stockholders
-21.02
+59.80%
-52.29
+70.25%
-175.77
+67.98%
-548.98
Diluted EPS
-1.94
+73.17%
-7.23
+86.56%
-53.79
Basic EPS
-1.94
+73.17%
-7.23
+86.56%
-53.79
Basic Average Shares
26.89
+10.61%
24.31
+137.49%
10.24
Diluted Average Shares
26.89
+10.61%
24.31
+137.49%
10.24
Diluted NI Availto Com Stockholders
-21.02
+59.80%
-52.29
+70.25%
-175.77
+67.98%
-548.98
Total Other Finance Cost
2.54
-16.26%
3.03
+372.17%
-1.11
-267.27%
0.67
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
523.71
+24.88%
419.38
+0.15%
418.76
-14.70%
490.94
Current Assets
268.29
+35.52%
197.97
+8.57%
182.34
-14.24%
212.62
Cash Cash Equivalents And Short Term Investments
171.28
+21.32%
141.19
+8.48%
130.15
+5.01%
123.93
Cash And Cash Equivalents
105.00
+23.22%
85.21
-14.52%
99.68
-19.57%
123.93
Other Short Term Investments
66.28
+18.42%
55.97
+83.72%
30.47
0.00
Receivables
74.37
+97.64%
37.63
+14.67%
32.82
-24.29%
43.34
Accounts Receivable
74.37
+97.64%
37.63
+16.24%
32.37
-24.07%
42.63
Inventory
13.95
+31.00%
10.65
+21.34%
8.78
-35.77%
13.66
Prepaid Assets
7.17
-3.38%
7.42
-14.06%
8.64
-26.92%
11.82
Restricted Cash
13.47
Other Current Assets
1.51
+40.04%
1.08
-44.89%
1.96
-93.82%
31.68
Total Non Current Assets
255.42
+15.36%
221.41
-6.35%
236.42
-15.06%
278.32
Net PPE
69.11
+18.12%
58.51
-1.47%
59.38
-29.55%
84.28
Gross PPE
94.62
+20.06%
78.81
-25.53%
105.83
-43.02%
185.75
Accumulated Depreciation
-25.52
-25.66%
-20.31
+56.28%
-46.45
+54.22%
-101.46
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
4.53
+0.00%
4.53
+0.00%
4.53
-27.84%
6.28
Machinery Furniture Equipment
11.55
+54.03%
7.50
-80.55%
38.54
-14.59%
45.12
Construction In Progress
7.45
+50.14%
4.96
+59.69%
3.11
-8.27%
3.39
Other Properties
56.30
+19.34%
47.17
+4.73%
45.04
-52.78%
95.40
Leases
14.80
+1.00%
14.65
+0.28%
14.61
-58.90%
35.56
Goodwill And Other Intangible Assets
182.00
+14.75%
158.60
-8.12%
172.62
-7.51%
186.65
Goodwill
13.52
0.00
Other Intangible Assets
168.48
+6.23%
158.60
-8.12%
172.62
-7.51%
186.65
Other Non Current Assets
4.32
+0.23%
4.31
-2.42%
4.41
-40.24%
7.38
Total Liabilities Net Minority Interest
215.53
+23.77%
174.13
-8.71%
190.74
-19.60%
237.24
Current Liabilities
108.91
+98.68%
54.82
-6.80%
58.82
-59.24%
144.30
Payables And Accrued Expenses
47.76
+126.74%
21.07
-11.48%
23.80
-69.71%
78.56
Payables
3.10
-64.00%
8.62
-25.78%
11.62
-76.58%
49.61
Accounts Payable
2.46
-69.06%
7.95
-22.31%
10.24
-77.75%
46.02
Current Accrued Expenses
44.66
+258.91%
12.44
+2.17%
12.18
-57.93%
28.95
Employee Benefits
Pensionand Other Post Retirement Benefit Plans Current
30.41
+79.01%
16.99
+18.64%
14.32
+8.48%
13.20
Current Debt And Capital Lease Obligation
8.95
+96.75%
4.55
+24.68%
3.65
-66.45%
10.87
Current Debt
4.54
+275.06%
1.21
+143.66%
0.50
-89.54%
4.75
Other Current Borrowings
4.54
+275.06%
1.21
+143.66%
0.50
-89.54%
4.75
Current Capital Lease Obligation
4.40
+32.01%
3.34
-8.53%
3.65
-40.42%
6.12
Current Deferred Liabilities
0.04
Current Deferred Revenue
0.04
Other Current Liabilities
11.27
+590.26%
1.63
-19.13%
2.02
-91.82%
24.67
Total Non Current Liabilities Net Minority Interest
106.62
-10.64%
119.32
-9.55%
131.92
+41.94%
92.94
Long Term Debt And Capital Lease Obligation
104.22
-7.63%
112.83
-2.42%
115.63
+74.50%
66.26
Long Term Debt
48.18
-7.20%
51.91
-1.47%
52.69
+743.01%
6.25
Long Term Capital Lease Obligation
56.05
-8.00%
60.92
-3.21%
62.94
+4.87%
60.01
Long Term Provisions
2.00
-83.33%
12.00
-45.45%
22.00
Non Current Deferred Liabilities
0.76
-21.55%
0.96
-38.14%
1.56
-41.33%
2.66
Non Current Deferred Taxes Liabilities
0.76
-21.55%
0.96
-38.14%
1.56
-41.33%
2.66
Other Non Current Liabilities
1.64
1.60
Preferred Securities Outside Stock Equity
Stockholders Equity
308.18
+25.66%
245.25
+7.56%
228.02
-10.13%
253.71
Common Stock Equity
308.18
+25.66%
245.25
+7.56%
228.02
-10.13%
253.71
Capital Stock
0.00
+50.00%
0.00
+0.00%
0.00
+100.00%
0.00
Common Stock
0.00
+50.00%
0.00
+0.00%
0.00
+100.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
29.25
+4.39%
28.02
+7.84%
25.98
+120.66%
11.77
Ordinary Shares Number
29.25
+4.39%
28.02
+7.84%
25.98
+120.66%
11.77
Additional Paid In Capital
1,680.74
+5.25%
1,596.89
+4.52%
1,527.78
+10.86%
1,378.12
Retained Earnings
-1,373.49
-1.55%
-1,352.47
-4.02%
-1,300.19
-15.63%
-1,124.42
Gains Losses Not Affecting Retained Earnings
0.94
+12.77%
0.83
+95.29%
0.42
0.00
Other Equity Adjustments
0.94
+12.77%
0.83
+95.29%
0.42
Total Equity Gross Minority Interest
308.18
+25.66%
245.25
+7.56%
228.02
-10.13%
253.71
Total Capitalization
356.36
+19.92%
297.16
+5.86%
280.70
+7.98%
259.95
Working Capital
159.38
+11.34%
143.15
+15.89%
123.52
+80.78%
68.33
Invested Capital
360.90
+20.96%
298.37
+6.29%
280.70
+6.04%
264.70
Total Debt
113.17
-3.59%
117.38
-1.59%
119.27
+54.63%
77.13
Capital Lease Obligations
60.45
-5.92%
64.25
-3.50%
66.58
+0.68%
66.13
Net Tangible Assets
126.18
+45.63%
86.65
+56.43%
55.39
-17.39%
67.06
Tangible Book Value
126.18
+45.63%
86.65
+56.43%
55.39
-17.39%
67.06
Current Provisions
10.53
-0.58%
10.59
-29.61%
15.04
-11.54%
17.00
Derivative Product Liabilities
0.00
-100.00%
3.52
+28.67%
2.73
+554.31%
0.42
Duefrom Related Parties Current
0.20
-54.38%
0.45
-37.15%
0.71
Dueto Related Parties Current
0.64
-3.74%
0.67
-51.56%
1.38
-61.62%
3.59
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
33.28
+216.78%
-28.50
+84.18%
-180.15
+43.56%
-319.15
Cash Flow From Continuing Operating Activities
33.28
+216.78%
-28.50
+84.18%
-180.15
+43.56%
-319.15
Net Income From Continuing Operations
-21.02
+59.80%
-52.29
+70.25%
-175.77
+67.98%
-548.98
Depreciation Amortization Depletion
25.22
+14.90%
21.95
-34.92%
33.73
-43.12%
59.31
Depreciation And Amortization
25.22
+14.90%
21.95
-34.92%
33.73
-43.12%
59.31
Other Non Cash Items
12.38
-28.31%
17.26
+224.54%
-13.86
-605.36%
2.74
Stock Based Compensation
32.16
+251.96%
9.14
+2903.07%
-0.33
-100.78%
41.98
Provisionand Write Offof Assets
0.14
-25.00%
0.18
-95.40%
3.91
+247.82%
1.12
Asset Impairment Charge
0.00
0.00
-100.00%
10.40
-95.05%
210.15
Deferred Tax
-0.34
+62.96%
-0.93
+98.11%
-49.12
Deferred Income Tax
-0.34
+62.96%
-0.93
+98.11%
-49.12
Operating Gains Losses
13.37
+338.88%
-5.60
+92.03%
-70.23
Gain Loss On Investment Securities
13.37
+1242.74%
-1.17
+98.33%
-70.23
Change In Working Capital
-15.60
+36.97%
-24.75
+35.29%
-38.24
-212.87%
33.88
Change In Receivables
-36.23
-599.44%
-5.18
-149.21%
10.53
+90.45%
5.53
Changes In Account Receivables
-36.23
-599.44%
-5.18
-149.21%
10.53
+90.45%
5.53
Change In Inventory
-3.44
-32.92%
-2.58
-365.13%
0.97
-58.51%
2.35
Change In Prepaid Assets
11.13
Change In Payables And Accrued Expense
12.10
+158.96%
-20.52
+58.26%
-49.17
-242.68%
34.46
Change In Other Working Capital
11.97
+237.75%
3.54
+716.35%
-0.57
+93.20%
-8.46
Change In Other Current Assets
-0.00
Change In Other Current Liabilities
-19.47
Investing Cash Flow
-61.52
-104.16%
-30.13
+31.09%
-43.73
+69.06%
-141.33
Cash Flow From Continuing Investing Activities
-61.52
-104.16%
-30.13
+31.09%
-43.73
+69.06%
-141.33
Net PPE Purchase And Sale
-19.02
-246.33%
-5.49
-4.59%
-5.25
+26.63%
-7.16
Purchase Of PPE
-19.02
-246.33%
-5.49
-4.59%
-5.25
+26.63%
-7.16
Capital Expenditure
-19.02
-246.33%
-5.49
+3.85%
-5.71
+60.12%
-14.32
Net Investment Purchase And Sale
-9.64
+60.86%
-24.64
+17.60%
-29.91
0.00
Purchase Of Investment
-55.68
+16.03%
-66.30
-39.09%
-47.67
0.00
Sale Of Investment
46.03
+10.49%
41.66
+134.51%
17.77
0.00
Net Business Purchase And Sale
-32.86
0.00
0.00
+100.00%
-127.00
Purchase Of Business
-32.86
0.00
0.00
+100.00%
-127.00
Net Intangibles Purchase And Sale
0.00
0.00
+100.00%
-0.46
+93.57%
-7.17
Purchase Of Intangibles
0.00
0.00
+100.00%
-0.46
+93.57%
-7.17
Net Other Investing Changes
-8.11
Financing Cash Flow
48.02
+8.75%
44.16
-76.29%
186.24
-5.61%
197.31
Cash Flow From Continuing Financing Activities
48.02
+8.75%
44.16
-76.29%
186.24
-5.61%
197.31
Net Issuance Payments Of Debt
-3.66
-13.55%
-3.23
-107.51%
42.95
+1404.71%
-3.29
Issuance Of Debt
0.00
0.00
-100.00%
48.55
0.00
Repayment Of Debt
-3.66
-13.55%
-3.23
+42.39%
-5.60
-70.05%
-3.29
Long Term Debt Issuance
0.00
0.00
-100.00%
48.55
0.00
Long Term Debt Payments
-3.66
-13.55%
-3.23
+42.39%
-5.60
-70.05%
-3.29
Net Long Term Debt Issuance
-3.66
-13.55%
-3.23
-107.51%
42.95
+1404.71%
-3.29
Net Common Stock Issuance
46.70
+0.45%
46.50
-67.49%
143.00
-27.65%
197.66
Proceeds From Stock Option Exercised
4.98
+459.26%
0.89
+212.63%
0.28
-90.33%
2.95
Net Other Financing Charges
197.66
Changes In Cash
19.79
+236.78%
-14.47
+61.56%
-37.63
+85.70%
-263.17
Beginning Cash Position
86.20
-14.37%
100.67
-27.21%
138.30
-65.55%
401.47
End Cash Position
105.99
+22.95%
86.20
-14.37%
100.67
-27.21%
138.30
Free Cash Flow
14.26
+141.96%
-33.99
+81.71%
-185.86
+44.27%
-333.48
Interest Paid Supplemental Data
6.41
-3.95%
6.68
+119.57%
3.04
+57.40%
1.93
Income Tax Paid Supplemental Data
1.27
+9.25%
1.17
-20.34%
1.47
+18.05%
1.24
Common Stock Issuance
46.70
+0.45%
46.50
-67.49%
143.00
-27.65%
197.66
Issuance Of Capital Stock
46.70
+0.45%
46.50
-67.49%
143.00
-27.65%
197.66
Net Preferred Stock Issuance
0.00
Preferred Stock Issuance
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category